KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Shares Outstanding (2016 - 2026)

Abbott Laboratories' Shares Outstanding history spans 18 years, with the latest figure at $2.0 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.12% to $2.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.0 billion, a 0.12% change, with the full-year FY2025 number at $2.0 billion, changed 0.27% from a year prior.
  • Shares Outstanding hit $2.0 billion in Q1 2026 for Abbott Laboratories, roughly flat from $2.0 billion in the prior quarter.
  • Over the last five years, Shares Outstanding for ABT hit a ceiling of $2.0 billion in Q1 2026 and a floor of $2.0 billion in Q1 2022.
  • Historically, Shares Outstanding has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2024.
  • Biggest five-year swings in Shares Outstanding: rose 0.06% in 2022 and later grew 0.32% in 2025.
  • Tracing ABT's Shares Outstanding over 5 years: stood at $2.0 billion in 2022, then grew by 0.07% to $2.0 billion in 2023, then increased by 0.18% to $2.0 billion in 2024, then rose by 0.27% to $2.0 billion in 2025, then grew by 0.07% to $2.0 billion in 2026.
  • Business Quant data shows Shares Outstanding for ABT at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $2.0 billion in Q3 2025.